Title HSJ Country/Territory United Kingdom Date 27/01/22 Description The covid pandemic has created challenges for many NHS services, including those dealing with patients with respiratory conditions.
Sponsored byBoehringer Ingelheim
A webinar, sponsored by Boehringer Ingelheim, at HSJ’s virtual respiratory forum looked at the impact on services for patients with idiopathic pulmonary fibrosis and how these could be improved post-covid.
At least 32,000 people in the UK have IPF, with 6,000 new cases a year. IPF is a chronic progressive lung disease with a prognosis that can be worse than some cancers, two and a half to five years post diagnosis. Treatments in the form of antifibrotics are available across the UK after accurate diagnosis and prescribed by designated specialist centres across England (differences exist within the devolved nations).
URL https://www.hsj.co.uk/quality-and-performance/tackling-covid-related-challenges-in-services-for-patients-with-respiratory-conditions/7031698.article Persons Nazia Chaudhuri